PDL BioPharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.11.20	EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q3 Earnings Report (RTTNews)
09.11.20	Ausblick: PDL BioPharma legt Quartalsergebnis vor (finanzen.net)
07.11.20	Ausblick: PDL BioPharma öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
10.09.20	PDL BioPharma Board Approves Spin-Off Of LENSAR; To Complete Spin-Off On October 1, 2020 (RTTNews)
09.09.20	PDL BioPharma Closes Divestiture Of Noden Pharmaceutical Business (RTTNews)
12.08.20	PDL BioPharma Reaches Settlement With Wellstat Parties - Quick Facts (RTTNews)
06.08.20	EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q2 Earnings Report (RTTNews)
05.08.20	Ausblick: PDL BioPharma verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
30.07.20	PDL BioPharma To Divest Noden Pharma Business To Stanley Capital For $48.25 Mln Cash (RTTNews)
07.05.20	EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q1 Earnings Report (RTTNews)
07.05.20	Ausblick: PDL BioPharma öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
11.03.20	EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q4 Earnings Report (RTTNews)
10.03.20	Ausblick: PDL BioPharma gewährt Anlegern Blick in die Bücher (finanzen.net)
28.02.20	PDL BioPharma Enters Cooperation Agreement With Engine Capital - Quick Facts (RTTNews)
09.12.19	PDL BioPharma Decides To Pursue Monetization Of Its Assets - Quick Facts (RTTNews)
06.11.19	PDL BioPharma Inc. Q3 adjusted earnings of -$ per share (RTTNews)
07.08.19	PDL BioPharma Inc. Q2 adjusted earnings of -$ per share (RTTNews)
05.08.19	Ausblick: PDL BioPharma informiert über die jüngsten Quartalsergebnisse (finanzen.net)
09.05.19	PDL BioPharma Inc. Q1 Income Climbs (RTTNews)
07.05.19	Ausblick: PDL BioPharma stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
14.03.19	PDL BioPharma Inc. Bottom Line Drops In Q4 (RTTNews)
12.03.19	Ausblick: PDL BioPharma legt Quartalsergebnis vor (finanzen.net)
06.11.18	PDL BioPharma Inc. Q3 adjusted earnings of -$ per share (RTTNews)
04.11.18	Ausblick: PDL BioPharma vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
24.09.18	PDL BioPharma Board Authorizes New $100 Mln Stock Repurchase Program (RTTNews)
11.06.18	Shlomo Yanai Elected to PDL BioPharma's Board of Directors (PR Newswire)
21.05.18	PDL BioPharma Names Dr. Jill Jene Vice President, Business Development (PR Newswire)
15.05.18	PDL BioPharma to Present at Two Upcoming Investor Conferences (PR Newswire)
09.05.18	PDL BioPharma Inc. Q1 adjusted earnings (RTTNews)
09.05.18	PDL BioPharma Announces First Quarter 2018 Financial Results (PR Newswire)
02.05.18	PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018 (PR Newswire)
16.04.18	PDL BioPharma to Hold Annual Meeting of Stockholders on June 8, 2018 (PR Newswire)
09.04.18	PDL BioPharma Shareholder, SevenSaoi Capital, Comments on the Nomination of Shlomo Yanai to the PDL Board of Directors and Delivers Letter to the Board Outlining Significant Concerns (PR Newswire)
03.04.18	PDL BioPharma to Present at the H.C. Wainwright Global Life Sciences Conference (PR Newswire)
08.03.18	EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q4 Earnings Report (RTTNews)
08.03.18	PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results (PR Newswire)
01.03.18	PDL BioPharma to Announce Fourth Quarter / Year-End 2017 Financial Results on March 8, 2018 (PR Newswire)
20.02.18	Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities (PR Newswire)
20.02.18	PDL BioPharma Says No Longer Pursue Proposed Acquisition Of Neos Therapeutics (RTTNews)
20.02.18	PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos (PR Newswire)
14.02.18	PDL BioPharma to Present at Two Upcoming Investor Conferences (PR Newswire)
30.11.17	ThoughtWorks' Bi-Annual Technology Radar Identifies Blockchain Gaining in the Enterprise (PR Newswire)
15.11.17	Noden Pharma Announces FDA Approval of Tekturna®(aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older (PR Newswire)
08.11.17	PDL BioPharma's Proposal to Acquire Neos Therapeutics Expires Today; PDL Urges Neos to Provide Update on Sale Process (PR Newswire)
07.11.17	PDL BioPharma to Present at Two Upcoming Investor Conferences (PR Newswire)
02.11.17	EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q3 Earnings Report (RTTNews)
02.11.17	PDL BioPharma Announces Third Quarter 2017 Financial Results (PR Newswire)
30.10.17	PDL BioPharma Issues Statement in Response to Neos Therapeutics Rejection of PDL Acquisition Proposal (PR Newswire)
30.10.17	Neos Therapeutics Board Rejects PDL BioPharma's Unsolicited Offer - Quick Facts (RTTNews)
30.10.17	Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	77.78	3.85 %	K V
CieFinRichemont	139.05	3.58 %	K V
UBS Group	29.21	2.64 %	K V
Sika	217.70	2.25 %	K V
Lonza Grp	541.80	1.46 %	K V
Swiss Re	132.60	-0.08 %	K V
Swisscom	504.00	-0.10 %	K V
Sonova Hldg	294.30	-0.71 %	K V
Nestle	74.02	-0.91 %	K V
Givaudan	3’888.00	-1.44 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu PDL BioPharma Inc.

Aktien Top/Flop

Meistgelesene Nachrichten